Elacestrant trials for Advanced Breast Cancer

All Elacestrant trials · All Advanced Breast Cancer trials

Phase breakdown

Recruiting trials studying Elacestrant for Advanced Breast Cancer

• BGB-43395 Alone or as Part of Combination Therapies in Participants With Breast Cancer and Other Advanced Solid Tumors
  NCT06120283 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 62 locations
• Elacestrant + Everolimus in Patients ER+/HER2-, ESR1mut, Advanced Breast Cancer Progressing to ET and CDK4/6i.
  NCT06382948 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 104 locations
• Safety of Elacestrant in ER+/HER2- and ESR1 Mutations MBC
  NCT06544577 · Phase: Not specified · Ages: 18 Years and older · Sex: Female · 1 location

Common questions

How many trials study Elacestrant for Advanced Breast Cancer?

3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.